NCT03596697View on ClinicalTrials.gov

A Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

June 4, 2021

Conditions
Hepatitis BInfectious DiseaseLiver Diseases
Interventions
DRUG

CRV431

Single or multiple dose(s) of CRV431

DRUG

Placebo

Single Placebo dose

DRUG

TDF

Single or multiple dose(s) of TDF

Trial Locations (3)

68502

Celerion, Inc, Lincoln

78229

Pinnacle Clinical Research, San Antonio

85283

Celerion, Inc, Tempe

Sponsors
All Listed Sponsors
lead

Hepion Pharmaceuticals, Inc.

INDUSTRY